Sara Álvarez
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Genomic variations and chromosomal abnormalities
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 26
- Acute Myeloid Leukemia Research 22
- Genetics 31
- Genomic variations and chromosomal abnormalities 12
- Genetics and Neurodevelopmental Disorders 9
- Genomics and Rare Diseases 7
- Co-authors
- Juan C. CigudosaMarı́a José CalasanzJavier Benı́tezMark WunderlichJames C. MulloyJavier SuelaVital HeviaJamie Wilhelm
- Journals
- Leukemia (5 papers)Current Urology Reports (5 papers)Clinical Cancer Research (3 papers)Genes Chromosomes and Cancer (3 papers)Oncogene (3 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Sara Álvarez
88 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 110
- Hematology 623
- Genetics 253
- Cancer Research 277
- Molecular Biology 982
- Oncology 324
Countries citing papers authored by Sara Álvarez
This map shows the geographic impact of Sara Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Álvarez more than expected).
Fields of papers citing papers by Sara Álvarez
This network shows the impact of papers produced by Sara Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Álvarez. The network helps show where Sara Álvarez may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara Álvarez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 9 | |
| 9 | 2019 | 21 | |
| 10 | 2017 | 7 | |
| 11 | 2016 | 15 | |
| 12 | 2013 | 28 | |
| 13 | 2012 | 21 | |
| 14 | 2010 | 61 | |
| 15 | 2007 | 28 | |
| 16 | 2007 | 29 | |
| 17 | 2006 | 29 | |
| 18 | 2005 | 15 | |
| 19 | 2001 | 28 | |
| 20 | The prevalence of depressive symptons and cognitive impaiment in patients older than 65 years admitted to a general hospital | 1998 | 2 |
About Sara Álvarez
Sara Álvarez is a scholar working on Hematology, Genetics, Genetics, Transplantation and Molecular Biology, having authored 91 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Genomic variations and chromosomal abnormalities (12 papers), Genetics and Neurodevelopmental Disorders (9 papers), Genomics and Rare Diseases (7 papers), Diabetes Treatment and Management (7 papers), Diabetes Management and Research (6 papers), Metabolism, Diabetes, and Cancer (6 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (623 citations), Genetics (253 citations), Cancer Research (277 citations), Molecular Biology (982 citations) and Oncology (324 citations). Sara Álvarez has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Juan C. Cigudosa, Marı́a José Calasanz, Javier Benı́tez, Mark Wunderlich, James C. Mulloy, Javier Suela, Vital Hevia, Jamie Wilhelm, Victoria Gómez and Yi Zheng. Their work appears in journals such as Leukemia, Current Urology Reports, Clinical Cancer Research, Genes Chromosomes and Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.